Global Health Policy Blog

CGD experts blog on global health issues such as health financing, drug resistance, clinical trials, vaccine development, HIV/AIDS, and health-related foreign assistance.

 

Failing to Deliver on Family Planning? Funding in Crisis

More than 5000 international personalities and technical experts are wrapping up the Women Deliver Conference in Copenhagen this week. The topic: how to empower women, reduce gender inequality, and improve the sexual and reproductive health of women and girls in low- and middle-income countries. Family planning and reproductive health commodities are central to this broader agenda. Yet according to our onsite sources, the conference has barely (if at all) remarked on the funding cuts that UNFPA, the United Nations Population Fund, has experienced since last year.

Next Up on the Universal Health Coverage Agenda: Value for Money

At the World Bank’s Annual Universal Health Coverage (UHC) Financing Forum this year, I took part in a mock competition to help determine the topic of next year’s forum. I was up against Larry Gostin, who argued that the 2017 forum should focus on equity and human rights, and Sara Bennett, who made the case for it to be the political economy. My pitch was for the forum to focus on efficiency—or value for money—in UHC reforms, and here’s why.

Confronting Antimicrobial Resistance: Can We Get to Collective Action?

Imagine if a small cut could evolve into a lengthy hospital stay, or worse; if doctors refused to perform surgery or transplants due to prohibitive risk during recovery; and if our collective gains against the world’s biggest infectious killers—HIV, malaria, tuberculosis, sexually transmitted infections, pneumonia, and more—slowed, stalled, and reversed. These nightmare scenarios could become the new global reality if common pathogens evolve to withstand and survive treatment with antimicrobial drugs, a phenomenon known as antimicrobial resistance (AMR).

How Could the Global Fund Get More Health for Its Money? Lessons from the Economics of Contract Theory

Our recent report on next generation financing models looks at how global health donors, specifically the Global Fund to Fight AIDS, Tuberculosis and Malaria, can enhance the health impact of grants by tying grant payments to achieved and verified results. Yet there are several ways to condition payments on performance, and some ways would likely work better than others.  Can economic theory suggest specific features of contract designs which would generate more health for the money?  

Pages

Tags

Experts